SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-018439
Filing Date
2019-04-05
Accepted
2019-04-05 16:39:52
Documents
17
Period of Report
2019-05-29
Effectiveness Date
2019-04-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv517860-def14a.htm DEF 14A 474409
2 GRAPHIC icon-bullet.gif GRAPHIC 134
3 GRAPHIC icon-bullet.jpg GRAPHIC 41073
4 GRAPHIC icon-chair.gif GRAPHIC 21669
5 GRAPHIC icon-chair.jpg GRAPHIC 55072
6 GRAPHIC icon-internet.jpg GRAPHIC 4976
7 GRAPHIC icon-mail.jpg GRAPHIC 4545
8 GRAPHIC icon-person.jpg GRAPHIC 4953
9 GRAPHIC icon-phone.jpg GRAPHIC 4214
10 GRAPHIC icon-qrcode.jpg GRAPHIC 4492
11 GRAPHIC lg_eloxx.jpg GRAPHIC 357794
12 GRAPHIC sg_neil-belloff.jpg GRAPHIC 74993
13 GRAPHIC sg_robert-ward.jpg GRAPHIC 60008
14 GRAPHIC tv517860_chrt-pie1.jpg GRAPHIC 862842
15 GRAPHIC tv517860_proxycard-p1.jpg GRAPHIC 132767
16 GRAPHIC tv517860_proxycard-p2.jpg GRAPHIC 98677
17 GRAPHIC tv517860_scantoview.jpg GRAPHIC 53172
  Complete submission text file 0001144204-19-018439.txt   2619840
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31326 | Film No.: 19735598
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services